|1||NCT01848561||Recruiting||A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)||
||8250||All||18 Years to 99 Years (Adult, Senior)||NCT01848561||P11-282||April 29, 2013||April 6, 2027||April 6, 2027||May 7, 2013||May 14, 2018||
|2||NCT03038100||Recruiting||A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer||
||Industry / Other||
||1300||Female||18 Years and older (Adult, Senior)||NCT03038100||YO39523
|IMagyn050||March 8, 2017||April 1, 2020||December 1, 2021||January 31, 2017||May 4, 2018||
† Study has passed its completion date and status has not been verified in more than two years.